Affordable Access

Publisher Website

Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer

Authors
Journal
Histochemistry and Cell Biology
0948-6143
Publisher
Springer-Verlag
Publication Date
Volume
129
Issue
5
Identifiers
DOI: 10.1007/s00418-008-0401-3
Keywords
  • Review
Disciplines
  • Medicine

Abstract

ErbB receptors (EGFR (ErbB1), ErbB2, ErbB3, and ErbB4) are important regulators of normal growth and differentiation, and they are involved in the pathogenesis of cancer. Following ligand binding and receptor activation, EGFR is endocytosed and transported to lysosomes where the receptor is degraded. This downregulation of EGFR is a complex and tightly regulated process. The functions of ErbB2, ErbB3, and ErbB4 are also regulated by endocytosis to some extent, although the current knowledge of these processes is sparse. Impaired endocytic downregulation of signaling receptors is frequently associated with cancer, since it can lead to increased and uncontrolled receptor signaling. In this review we describe the current knowledge of ErbB receptor endocytic downregulation. In addition, we outline how ErbB receptors can escape endocytic downregulation in cancer, and we discuss how targeted anti-cancer therapy may induce endocytic downregulation of ErbB receptors.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Mechanisms of ErbB receptor negative regulation an...

on Experimental Cell Research Jan 01, 2009

Downregulation of erbB3 abrogates erbB2-mediated t...

on International Journal of Cance... May 01, 2007

ErbB receptors: new insights on mechanisms and bio...

on Trends in Cell Biology Jan 01, 2006

ErbB receptors: new insights on mechanisms and bio...

on Trends in Cell Biology December 2006
More articles like this..